ghk cu and reta GHK-CU GHK-CU – Research Peptide |

KLOW is a streamlined 4-in-1 protocol combining BPC-157, TB-500, GHK-Cu, and KPV, each selected for its role in supporting recovery pathways, inflammatory balance, tissue integrity, and skin health

Researchers report increased stability in brain tissue following N-terminal acetylation, potentially indicating prolonged effects compared to Semax [6]

Topical and intraperitoneal addition of TB4 increased re-epithelialisation by 42% over saline controls at day 4, and by up to 61% at day 7 post-wounding

All PSPeptides products are sold exclusively for research and laboratory use.

For oral administration, clinical trials have studied doses ranging from 1-30 mg daily, with typical protocols using 1-2 mg per dose on an empty stomach